Assessing and Enhancing Survivorship Care

Overview

Currently, there are over 18 million cancer survivors in the United States (US). This number is expected to continue to increase, as more people are living longer after diagnosis given advances in treatment. Care needs for cancer survivors persist beyond primary treatment and include management or prevention of side effects, detection of recurrence or new cancers, and support for healthy behaviors (such as tobacco control and physical activity). As a result, survivors need risk-informed, coordinated, and often multidisciplinary long-term follow-up care. However, approaches to cancer survivorship care vary widely across the US.

Despite the existence of recommendations and long-term follow-up guidelines for some cancers, the lack of a national standard for cancer survivorship care has impeded advancements in research and clinical care, most notably with regards to ensuring equitable care, measuring care quality, and supporting reimbursement for components of care received. Recently, as part of the Cancer Moonshot and the President’s Cancer Cabinet, the National Cancer Institute (NCI) and Veterans Affairs (VA), in collaboration with several Health and Human Services (HHS) agencies developed the National Standards for Survivorship Care. These standards define the (1) essential health system policy and process components of survivorship care programs; and (2) outcomes to evaluate the quality of survivorship care. The process to develop these standards included a landscape review of relevant guidelines, literature, quality frameworks, and prior work outside of the US, as well as national consensus meetings of subject matter experts to prioritize indicators. The final standards are being piloted in VA National TeleOncology’s new comprehensive survivorship program, which is scheduled to be implemented in 2024.

The short-term goal of the supplemental funding is to support research to better define and improve survivorship care that is accessible by survivors within each cancer center or organization’s catchment area using the national standards as a framework.

Funded Sites

To explore funded sites, click on the icon in the top left corner of the map, click on any pin on the map, or scroll down to view a funded initiatives table.

 

Legend

Funded Site Pin Color Year
Cancer Center
Brown
2024
Institution
Light Green
2024
 
Cancer Center Address Cancer Survivorship
FY24
Fred Hutchinson Cancer Research Center exit disclaimer 1100 Fairview Ave. N., Seattle, WA 98109 Check Mark
Masonic Cancer Center at the University of Minnesota exit disclaimer 420 Delaware St. SE, Minneapolis, MN 55455 Check Mark
Norris Cotton Cancer Center at Dartmouth-Hitchcock exit disclaimer One Medical Center Drive, Lebanon, NH 03756 Check Mark
University of Kentucky, Markey Cancer Center exit disclaimer 800 Rose St., Lexington, KY 40536 Check Mark
University of Nebraska Medical Center exit disclaimer 42nd and Emile St, Omaha, NE 68198 Check Mark
Stanford Cancer Institute exit disclaimer 265 Campus Drive, Stanford, California 94305 Check Mark
St. Jude Children's Research Hospital exit disclaimer 262 Danny Thomas Place, Memphis, TN 38105 Check Mark
Wake Forest Baptist Medical Center Comprehensive Cancer Center exit disclaimer 1 Medical Center Blvd., Winston-Salem, NC 27157 Check Mark
Winship Cancer Institute of Emory University exit disclaimer 1365C Clifton Road, Atlanta, GA 30322 Check Mark
Yale Cancer Center exit disclaimer 333 Cedar St. New Haven, CT 06520 Check Mark
Institution Address FY24
Baylor College of Medicine exit disclaimer 1 Baylor Plz, Houston, TX 77030 Check Mark
University of Iowa exit disclaimer Iowa City, IO 52242 Check Mark
University of Texas Health Science Center Houston exit disclaimer 7000 Fannin, Suite 1706 Houston, TX 77030 Check Mark
University of Michigan at Ann Arbor exit disclaimer 500 S State St, Ann Arbor, MI 48109 Check Mark
University of Southern California exit disclaimer Los Angeles, CA 90007 Check Mark
Kaiser Foundation Research Institute exit disclaimer 2000 Broadway Oakland, CA 94612 Check Mark
Fred Hutchinson Cancer Center exit disclaimer 1100 Fairview Ave N, Seattle, WA 98109 Check Mark
Rutgers Biomedical and Health Sciences exit disclaimer 65 Bergen Street, Suite 1441 Newark, NJ 07107 Check Mark
Last Updated
January 16, 2025